Glossy interviews BelliWelli CEO and co-founder Katie Wilson about the brand’s successful Walmart playbook, which includes celeb cameos.
What happened
For the Wellness Briefing, Glossy interviews BelliWelli CEO and co-founder Katie Wilson about the brand’s Walmart playbook, which includes celeb cameos, giveaways, endcap marketing and fashion partnerships. Additionally, Oura delays its IPO, Function hires its first CMO, and Europe-based biohacking chain The Longevity Suite hits the high seas. BelliWelli is using a media company playbook to supercharge fiber sales at Walmart
Why it matters
In a lot of ways, 6-year-old supplement maker BelliWelli operates more like a media company than a fiber brand.
On October 2, the company launched an endcap program into 3,200 Walmart doors that encapsulates this holistic marketing strategy. It includes a giveaway, snackable celebrity content, a fashion partnership, an evocative OOH marketing strategy and boots-on-the-ground consumer outreach.
“We try to bring people in and make them feel a part of [the brand] versus serving you another static [post] explaining why fiber matters,” BelliWelli CEO and co-founder Katie Wilson told Glossy. “Of course, it’s great to drive a bunch of brand awareness, but we want customers to feel like they’re part of this journey.”
This news brief is based on reporting published by Glossy on 2026-10-07. The original report is linked below.
Glossy
https://www.glossy.co/beauty/wellness/wellness-briefing-fiber-brand-belliwellis-walmart-playbook-includes-celeb-cameos-giveaways-and-fashion-partnerships/This independent news brief is based on the public source identified above. It is an original summary or translation, not a reproduction of the source article. Rights in source text, research, trademarks and images remain with their respective owners; images are used under the licence or permission identified in the credit. Rights holders may contact rights@goodproductasia.com with evidence of ownership. Verified concerns will be corrected, replaced or removed promptly. This report is not investment, legal, medical or purchasing advice.








